Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to evaluate the efficacy and safety of a fixed-dose escitalopram combination relative to its component monotherapies and to placebo in patients with major depressive disorder.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
540
Southwest Health, Ltd
Phoenix, Arizona, United States
Alpine Clinical Research
Boulder, Colorado, United States
Montgomery Asberg Depression Rating Scale (MADRS)
Hamilton Depression Rating Scale (HAMD)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Radiant Research, Inc.
Denver, Colorado, United States
Clinical Neuroscience Solutions, Inc.
Orlando, Florida, United States
Cunningham Clinical Research, LLC
Edwardsville, Illinois, United States
Midwest Center for Neurobiological Medicine
Oakbrook Terrace, Illinois, United States
Capital Clinical Research Associates
Rockville, Maryland, United States
Summit Research Network (Michigan), Inc.
Okemos, Michigan, United States
CNS Research Institute
Clementon, New Jersey, United States
Center for Emotional Fitness
Moorestown, New Jersey, United States
...and 8 more locations